The Nucleophosmin (NPM)-ALK fusion protein resulting from translocation involving the ALK gene on 2p23, as well as the oncogenic role of these fusion proteins, has been studied extensively in ALK-positive ALCL [4,5,6]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.